Home/Filings/8-K/0001193125-25-205020
8-K//Current report

Lyell Immunopharma, Inc. 8-K

Accession 0001193125-25-205020

$LYELCIK 0001806952operating

Filed

Sep 15, 8:00 PM ET

Accepted

Sep 16, 4:22 PM ET

Size

132.8 KB

Accession

0001193125-25-205020